Related Experiment Video
Updated: May 25, 2026

13:19
Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
Published on: November 2, 2013
International trends in prostatic cancer
International Journal of Cancer
|February 15, 1984
Summary
Prostate cancer incidence and mortality rates vary significantly worldwide, with higher rates in North America and Scandinavia. Differences in diagnostic practices and reporting of latent tumors may explain variations in prostate cancer statistics and survival rates.
Area of Science:
- Epidemiology
- Oncology
- Public Health
Background:
- Prostate cancer incidence and mortality show a 120-fold variation globally, with high rates in North America and Scandinavia, and low rates in East Asia.
- Geographic disparities exist, with highest reported mortality in certain Caribbean nations, though morbidity data is often unavailable.
- Both incidence and mortality rates for prostate cancer are increasing globally, particularly in regions with previously low frequencies.
Purpose of the Study:
- To analyze global variations in prostate cancer incidence and mortality rates.
- To investigate potential factors influencing the observed disparities, including diagnostic practices and the reporting of latent tumors.
- To highlight the need for standardized reporting and classification of prostate cancer to improve statistical comparability.
Main Methods:
- Analysis of available international data on prostate cancer incidence and mortality rates.
- Comparison of mortality-to-incidence ratios across different countries and regions.
- Review of factors potentially affecting statistical accuracy, such as diagnostic methods and the detection of latent prostatic carcinomas.
Main Results:
- Significant geographic variations in prostate cancer incidence and mortality were confirmed, with notable differences in mortality-to-incidence ratios.
- Lower mortality-to-incidence ratios were observed in North America, Hawaii, and Scandinavia.
- Increasing incidence trends in North America were not consistently matched by rising mortality, suggesting potential influences of diagnostic practices and treatment advances.
Conclusions:
- Variations in diagnostic practices and the inclusion of latent tumors in statistics contribute to the uncertainty in comparing global prostate cancer data.
- Advances in treatment may also play a role in improved survival rates observed in some regions.
- Standardizing the classification and reporting of prostate cancer, potentially by separating latent forms, is crucial for accurate international comparisons.
Related Concept Videos
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
Disorders of the Male Reproductive System
Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra. Symptoms...
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra. Symptoms...
Cancer Survival Analysis
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...

